Status:

COMPLETED

Preliminary Testing of New Treatment for Chronic Leg Wounds

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Gene Vector Laboratory

Conditions:

Varicose Ulcer

Eligibility:

All Genders

18-90 years

Phase:

PHASE1

Brief Summary

Most chronic (long-lasting) wounds of the leg (also known as venous ulcers) fail to heal in a reasonable period of time. Although researchers have made great progress in understanding how the body rep...

Detailed Description

Most chronic wounds of the leg fail to heal in a reasonable period of time. In fact, despite considerable advances in elucidating the molecular basis of wound repair, attempts to develop new therapies...

Eligibility Criteria

Inclusion Criteria:

  • Patient must have a venous leg ulcer.
  • Patient must have failed at least 6 weeks of limb compression.
  • Wound must be free of necrotic debris.
  • Wound must be greater than 5 cm2 and less than 20 cm2.
  • Wound must be more than 6 months old.
  • Affected limb must have an ankle-brachial index (ABI) > 0.85.
  • Patient must be more than 18 years old.

Exclusion Criteria:

  • Any active cancer or cancer in remission for less than 10 years.
  • Patients with life expectancy of less than 6 months.
  • Liver function tests (Alanine Transaminase(ALT) Aspartate Amino Transfer (AST) Alkaline Phosphatase (ALK PHOS) and bilirubin) greater than 1.5x upper limit of normal for the reference lab.
  • Patients with intercurrent organ damage or medical problems.
  • Pregnant or lactating females.
  • Any requirement for systemic corticosteroids or immunosuppressives, or history of corticosteroid or immunosuppressive use in the 4 weeks previous to study entry.
  • Seropositive for hepatitis B surface antigen or hepatitis C antibody.
  • Any concurrent medical illness that may be exacerbated by PDGF-B/Ad5 administration.

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00000431

Start Date

January 1 2005

End Date

March 1 2011

Last Update

May 13 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104